LCN2 and prostate cancer: Lipocalin2 (LCN2, also known as neutrophil gelatinase-associated lipocalin), is dysregulated in a variety of cancers such as pancreatic cancer [3], prostate cancer [4], and hepatocellular carcinoma [5].